{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T18:21:49Z","timestamp":1648923709547},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.transci.2011.07.010","type":"journal-article","created":{"date-parts":[[2011,8,21]],"date-time":"2011-08-21T06:14:55Z","timestamp":1313907295000},"page":"157-160","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Blastic Mantle Cell Leukemia"],"prefix":"10.1016","volume":"45","author":[{"given":"Oktay","family":"Bilgir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferda","family":"Bilgir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nukhet","family":"Eliyatkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Calan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Alper Ercan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tolgay","family":"Isikyakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferit","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2011.07.010_b0005","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood.V87.11.4483.bloodjournal87114483","article-title":"Mantle cell lymphoma: an entity comes of age","volume":"87","author":"Weisenburger","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.transci.2011.07.010_b0010","first-page":"115","article-title":"Mantle-cell lymphoma","volume":"36","author":"Campo","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1016\/j.transci.2011.07.010_b0015","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","article-title":"Mantle cell lymphoma: a clinicopathologic study of 80 cases","volume":"89","author":"Argatoff","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.transci.2011.07.010_b0020","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<567::AID-CNCR20>3.0.CO;2-Z","article-title":"Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors","volume":"82","author":"Bosch","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.transci.2011.07.010_b0025","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1126\/science.6610211","article-title":"Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation","volume":"224","author":"Tsujimoto","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.transci.2011.07.010_b0030","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood.V86.7.2715.2715","article-title":"Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma","volume":"86","author":"de Boer","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.transci.2011.07.010_b0035","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V91.8.2977.2977_2977_2984","article-title":"P16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variant of non-Hodgkin\u2019s Lymphomas","volume":"91","author":"Pinyol","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.transci.2011.07.010_b0040","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1182\/blood-2004-06-2275","article-title":"Allogeneic hematopoietic cell transplantation after fludarabine and 2Gy total body irradiation for relapsed and refractory mantle cell lymphoma","volume":"104","author":"Maris","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.transci.2011.07.010_b0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","article-title":"Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data","volume":"16","author":"Banks","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.transci.2011.07.010_b0050","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/sj.leu.2402272","article-title":"Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype","volume":"15","author":"Bernard","year":"2001","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.transci.2011.07.010_b0055","first-page":"2159","article-title":"BCL-1\/cyclinD1 oncoprotein oscillates and subverts the G1phase control in B cell neoplasms carrying the t(11;14) translocation","volume":"9","author":"Lukas","year":"1994","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.transci.2011.07.010_b0060","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants","volume":"93","author":"Bea","year":"1999","journal-title":"Blood"},{"issue":"5\u20136","key":"10.1016\/j.transci.2011.07.010_b0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3109\/10428190109097656","article-title":"Secondary chromosome changes in mantle cell lymphoma: cytogenetic and fluorescence in situ hybridization studies","volume":"40","author":"Bigoni","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.transci.2011.07.010_b0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"1","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.transci.2011.07.010_b0075","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1200\/JCO.2005.02.4364","article-title":"Phase I to II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in patients with advanced chronic lymphocytic leukemia","volume":"30","author":"O\u2019Brien","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2011.07.010_b0080","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/01.cad.0000217432.71741.da","article-title":"Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma","volume":"17","author":"Eucker","year":"2006","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.transci.2011.07.010_b0085","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1158\/0008-5472.CAN-06-1962","article-title":"Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments","volume":"3","author":"Lepelletier","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.transci.2011.07.010_b0090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.leukres.2004.06.009","article-title":"Transcriptional profiling and assessment of cell lines as in vitro models for mantle cell lymphoma","volume":"29","author":"Ek","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.transci.2011.07.010_b0095","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1200\/JCO.2005.05.019","article-title":"Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways","volume":"23","author":"Fernandez","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2011.07.010_b0100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/annonc\/mdn656","article-title":"Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study","volume":"20","author":"Goy","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.transci.2011.07.010_b0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.leu.2404959","article-title":"Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo","volume":"22","author":"Wang","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.transci.2011.07.010_b0110","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood-2006-04-015586","article-title":"Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma","volume":"5","author":"Rudelius","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.transci.2011.07.010_b0115","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1200\/JCO.2008.20.7977","article-title":"Phase III study to evaluate temsirolimus compared with investigator\u2019s choice therapy for the treatment of relapsed or refractory mantle cell lymphoma","volume":"23","author":"Hess","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2011.07.010_b0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.leu.2404471","article-title":"Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma","volume":"21","author":"Haritunians","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.transci.2011.07.010_b0125","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood-2004-03-1091","article-title":"Antitumor activity of rituximab plus thalidomide in patients with relapsed\/refractory mantle cell lymphoma","volume":"8","author":"Kaufmann","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.transci.2011.07.010_b0130","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2141.2009.07626.x","article-title":"Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma","volume":"145","author":"Habermann","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2011.07.010_b0135","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1200\/jco.2003.09.057","article-title":"Flavopiridol in untreated or relapsed mantle-cell lymphoma: results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group","volume":"9","author":"Kouroukis","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050211001273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050211001273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T13:08:14Z","timestamp":1592831294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050211001273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1473050211001273"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2011.07.010","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}